Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial

BACKGROUND: The CRASH-2 trial showed that early administration of tranexamic acid (TXA) safely reduces mortality in bleeding in trauma patients. Based on data from the CRASH-2 trial, global mortality data and a systematic literature review, we estimated the number of premature deaths that might be a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ker, Katharine, Kiriya, Junko, Perel, Pablo, Edwards, Phil, Shakur, Haleema, Roberts, Ian
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2012
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3314558/
https://ncbi.nlm.nih.gov/pubmed/22380715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-227X-12-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares